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SUMMARY
This paper aims to give a broad overview of the scienti-
fic findings related to Age-related hearing impairment that is a
complex disorder, with both environmental as well as genetic
factors contributing to the impairment. The involvement of
several environmental factors has been partially elucidated. A
first step towards the identification of the genetic factors has
been made, which will result in the identification of susceptibi-
lity genes, and will provide possible targets for the future treat-
ment and/or prevention of ARHI.
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RIASSUNTO
La perdita uditiva legata all’età anche nota come pre-
sbiacusia è una delle patologia complessa al cui sviluppo con-
tribuiscono sia fattori ambientali sia genetici. Il ruolo dei fatto-
ri ambientali, l’importanza dei geni coinvolti, le attuali strate-
gie terapeutiche e le potenziali prospettive terapeutiche e pre-
ventive future vengono trattate alla luce dei più recenti contri-
buti scientifici.
Parole chiave: Perdita uditiva legata all’età, presbiacusia, tin-
nitus, sordità
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Introduction
Age-related hearing impairment (ARHI) or
presbycusis is the most common sensory deficit in
the elderly and has become a severe social and
health problem. Deafness is the fourth most com-
mon not infectious disease in the world after the
arthritic and rheumatic diseases, cardiovascular and
mental diseases. In Italy hearing loss is at fifth
place among all disabling diseases of old age, with
an incidence rate of 8.4%(1). In 1999 The World
Health Organization (WHO) has estimated that
worldwide over 580 million people, older than 60
years old, are affected by ARHI. This number, as a
result of lengthening of life expectancy, probably
will increase with an estimate for 2020 of over one
billion people (http://www.who.int/en/).
Several studies in scientific literature tried to
define deafness incidence after 65 years of age with
conflicting results (from 13% to 80%). However
this in-homogeneity is explicable, because these
studies were based on different defining criterias of
hearing loss(2-5). Considering only subjects with hea-
ring loss equal or greater than 40 dB (average
degree of deafness according to the Bureau
International d’Audio-Phonologie) Cianfrone et al.
estimated that in Italy 30% of the population older
than 60 years has hearing problems(6). It was agreed
that this auditory dysfunction represents a physiolo-
gical involution process which several factors can
contribute. These factors, acting individually or
together during lifetime, induce a cumulative dama-
ge of the auditory system characterized by reduced
hearing sensitivity and speech understanding noisy
environments, slowed central processing of acou-
stic information, and impaired localization of sound
sources(7,8).
In its most typical form, ARHI is bilateral,
symmetric, sensorineural, progressive and initially
more pronounced in the high frequencies, but over
time it also extend to medium-low frequencies
becoming pantonal and disabling. Presbycusis suf-
ferers first have a high tone hearing loss with redu-
ced ability to perceive sounds of high pitch (door-
bell, telephone ring), but during the years, show a
progressive reduced intelligibility of voice messa-
ges particularly in noisy and/or reverberant liste-
ning situations, finally they usually lose the ability
to detect, identify, and localize sounds. Older adults
frequently complain: “I can hear you, but I can’t
understand you”. Verbal communication difficulties
bring these patients to social isolation, depression,
anxiety, social dissatisfaction that leads to a more or
less rapid cognitive decline resulting in a ‘dementia
senile’(7-9). Since there is not a specific medical or
surgical therapy there is no way to reverse presby-
cusis, the only treatment are Hearing aids that do
not restore hearing to normal but improve patient’s
ability to communicate especially when the impair-
ment of verbal discrimination is low
Human age related hearing loss
Hearing loss is typically sensorineural bilateral
symmetric and progressive, initially limited to high
frequencies but over time also extended to the mid-
low frequencies becoming pantonal. ARHI is cau-
sed by changes in peripheral (degeneration of hair
cells, cochlear neurons and stria vascularis) and
central auditory systems (consequent to peripheral
modifications or changes in the neurobiologic acti-
vity underlying central processing of auditory infor-
mations). Consequences are reduced sensitivity,
tuning sharpness, compression, and reduced signal-
to-noise ratios, deficits in auditory discrimination,
temporal processing, processing of degraded audi-
tory signals or when embedded in competing acou-
stic signals. In presbycusis a very common symp-
tom is tinnitus that constantly change frequency and
intensity with negative psychological repercus-
sions(8,9). Usually tinnitus diminished or disappeared
with hearing loss increasing(10).
By analyzing human temporal bones,
Schuknecht and Gacek distinguished six distinct
forms of ARHI, with different pathologic changes
correlated with a different audiologic pattern(11).
According to this classification presbycusis can be
divided into: Sensory presbycusis, Neural presby-
cusis, Strial presbycusis, Cochlear conductive pre-
sbycusis, Indeterminate presbycusis, Mixed presby-
cusis. Sensory presbycusis is defined by the atrophy
of neurosensory and/or supporting cells of the basal
turn of Corti’s organ with secondary degeneration
of neurons; audiometric curve shows bilateral sen-
sorineural hearing loss for high frequencies, with a
verbal ability discrimination usually preserved
(Figure 1a).
Degenerative processes, that first affect outer
hair cells and later internal hair cells, can be
emphasized by the simultaneous presence of other
etiopathogenetic factors such as damage from noise
exposure, which elderly is particularly susceptible,
or comorbidities like renal failure and/or cardiova-
scular disease. Neural presbycusis is characterized
by a cochlear and central auditory path neuronal
degeneration. The typical audiometric profile is a
moderate hearing loss bilaterally, pantonal, more
pronounced for high frequencies (Figure 1b) and
usually with a significant reduction of word discri-
mination.
Even if neuronal loss can start at any age, neu-
ral damage clinically appears when neural units fall
below the minimum level required for the acustic
messages processing. The anatomical alteration of
metabolic presbycusis is the stria vascular degenera-
tion that probably change biochemical endolymph
features. The corresponding clinical manifestation is
a bilateral sensorineural, pantonal and flat, hearing
loss with normal speech intelligibility (Figure 1c).
In 1991 Willot suggested that a high metabolic
activity of the stria vascularis can produce an
excess of oxidative processes and free radicals that,
reacting with intracellular proteins, lipids and
DNA, damage itself(12). Actually the relationship
between free radicals and aging is not already clear.
The cochlear conductive or mechanical presbycusis
is characterized by anatomical alterations of the
basilar membrane and spiral ligament while Corti’s
organ and cochlear neurons are relatively normal.
Clinically, hearing deficit is established by a slowly
progressive bilateral sensorineural hearing loss for
high frequencies with a speech discrimination com-
patible with hearing impairment (figure 1d).
Indeterminate presbycusis is not similar to any
of the previous forms (figure 1e), while mixed pre-
sbycusis is the result of the combination of different
types of presbycusis.
For example a sensory presbycusis associated
with strial presbycusis is characterized by a panto-
nal flat hearing loss with a sharp drop of the higher
frequencies (figure 1f).
Recently some authors, even if admit the
importance of this etiopathogenetic classification,
criticize its real clinical application because usually
more than one type of inner ear lesion occur with
age; infact “pure” forms of presbycusis are difficult
to discriminate with common audiometric techni-
ques and also presbycusis can be the result of phy-
siological alterations and not histopathological
lesions.
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Fig. 1A: Types of Age related hearing loss and
relative speech discrimination according to
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Risk factors
Nowadays, presbycusis is defined as the inevi-
table process of physiological aging of the whole
auditory system, a complex disorder caused by
environmental and genetic factors even if is still not
known how these factors contribute to the etiology
of the disease, how they interact each other and
what their individual contribution is.
This involution process begins early, since the
age of 18-20 years, with a decrease in auditory sen-
sibility, limited only to high frequencies and favo-
red by factors closely related to the life such as
acoustic pollution, ototoxic drugs treatment, high
fat diets, etc.(13)
So the age of onset of this phenomenon and its
clinical evolution are unpredictable because the
biological causal mechanisms can act at any age.
Enviromental factors
Scientific community has identified many
environmental factors that predispose and/or  acce-
lerate ARHI development. These factors, both isola-
ted and concomitantly present, are responsible of a
cumulative damage on one or more parts of the ear
structures up to the cortical areas of the temporal
lobe, that causes, with aging, a constant decline in
hearing acuity. 
Noise Exposure
Excessive noise exposure produces mechani-
cal or metabolic cochlear damage with primary
degeneration of the outer hair cells, and later also of
the inner hair cells, probably induced by free radi-
cals and reactive endogenous substances. Some
subjects are more sensitive to noise due to a higher
vulnerability of the hair cells(14,15).
Exposure to Chemicals
Exposure to industrial chemicals (toluene, trich-
loroethylene, styrene and xylene) can produce ARHI
especially if in combination with noise exposure, as
demonstrated by Sliwinska-Kowalska et al. further-
more, Chang et al. reported that even at low doses
chemical solvents might damage the inner ear(16,17).
Smoking and Alcohol
The effect of tobacco smoking on hearing loss
is not clear. Some authors reported that smoking,
reducing oxygen supply in the inner ear, may cause
either cochlear damage and mitochondrial muta-
tions, resulting in hearing loss; it’s also  universally
accepted that alcohol abuse increases the risk of
ARHI in heavy drinkers(18).
Ototoxic Medication
Ototoxic drugs can cause reversible or non-
reversible hearing loss predominantly in the high
frequencies, especially in older subjects with alte-
red liver and renal functions that can induce toxic
blood medication levels. Examples of frequently
used ototoxic medication are aminoglycoside anti-
biotics, chemotherapeutics like cisplatin, salicylate
and loop diuretics that usually cause a reversible
sensorineural hearing loss strongly correlated to
dose, timing and duration of therapy, but in presen-
ce of genetic mutations (i.e. A1555G mutation in
the small ribosomal RNA gene) causes from severe
to profound sensorineural hearing loss(19,20).
Medical Factors
The relationship between sensorineural hea-
ring impairment and diabetes mellitus has been
demonstrated probably determined by micro-angio-
pathic lesions in the inner ear(21).
Many studies have looked for a possible asso-
ciation between CVD and ARHI, particullary in the
Framingham cohort was found a clear correlation
between low-frequency hearing loss and cardiova-
scular events and risk factors(22). Renal failure cau-
ses high frequencies hearing loss through different
mechanisms (chronic dialysis, uraemic neuropathy,
electrolyte imbalance etc..)(23). Head trauma can pro-
duce hearing loss through the lesion of the cochlea
or inner ear hemorrhage(24,25).It’s known that
Immune System can have a role in ARHI develop-
ment, according to Iwai et al. study, a pathogen-
induced infections may induce a dysfunction of the
immune system followed by a decline in hearing
capacity (Autoimmune hearing loss)(26).
Diet
To date the role of diet in presbycusis is not
clear with different and not univocal results among
different studies, but It has been suggested that a
poor nutritional status has an effect on ARHI(27,28).
Hormones
The clinical evidences of a strong correlation
between human hormones levels and hearing loss
are supported by Hederstierna et al. and Hultcrantz
et al. which revealed that estrogenous therapy in
menopausal women reduce ARHI development
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while progestin have a negative effect(29-31).
Socioeconomic Status
Lower social class and a low level of educa-
tion are correlated with hearing impairment proba-
bly secondary to risk factors prevalent in lower
socioeconomic classes lifestyle (smoking, heavy
drinking, exposure to occupational noise)(32).
Genetic factors
Even if little is known about the genes invol-
ved in ARHI, it is expected that many genes will
participate in the etiology of ARHI. In the last years
scientific research has focused its attention on the
relationship between presbycusis and genetic sub-
strate, with new possible future therapeutic strate-
gies. Due to the significant similarities of the audi-
tory system between mice and humans, mice are
very useful as a model for human hearing loss.
Erway et al through a research conducted on
“inbread” mouse, have identified a recessive gene
located on chromosome 10, called AHL1 (Age
Hearing Loss-1), associated with the degeneration
of Corti’s organ, vascular stria, spiral ligament and
Corti’s spiral ganglion(33). A second locus AHL2
responsible for this disease was identified on chro-
mosome 5 and third AHL3 on chromosome 17(34,35).
The close correlation between the human audi-
tory system and animal (mice) and the identifica-
tion of genes responsible for presbycusis, have
justified new genetic studies of association and
linkage, conducted on family groups and samples
of populations, without encouraging results to date.
Fischel-Ghodsian et al demonstrated, in patients
with ARHI, a highly significant increase in mito-
chondrial mutations in auditory tissue(36). The mito-
chondrial alterations that occur most frequently in
humans are the mtDNA 4977 deletion and the cyto-
chrome oxidase mitochondrial gene mutation.
These changes can induce a cellular metabolic alte-
rations resulting in increased oxygen free radicals
(ROS), cellular damage and apoptosis of inner,
outer hair cells and first neuron(37).
In the future the study of genetic factors of
hearing loss probably  will  explain the relationship
between genetic damage and presbycusis, iden-
tifying specific genetic mutations associated with
this disease. The integration of the data concerning
genetic background and environmental risk factors
will verify each individual hearing susceptibility.
This will make possible a “drug-genomic” thera-
peutic approach or genetic engineering approaches. 
Treatment strategy
Actually the only intervention available for
subjects with ARHI is a hearing aid that can impro-
ve the hearing ability but in a limited number of
affected individuals due to the limited efficacy in
improving speech understanding, especially in
noisy environments. Possible pharmacological stra-
tegies are antioxidants and growth factors(38).
Anyway pharmacological substances can be
used with systemic or local therapy. But while
systemic therapy requires high doses of the drug
potentially toxic, on the other side local therapy is
invasive and potentially harmful for the cochlea. In
the future, this problem can be solved by new and
safer administration routes. A better understanding
of the molecular and cellular processes taking place
in the inner ear are necessary for possible future
therapies. One of the possible future strategies is
gene therapy. This is confirmed by the introduction
of Math1, a gene that induces, in mice, regrowth of
hair cells with the recovery of hearing abilities(39).
Another treatment strategy under development
is the implantation of stem cells supported by Ito et
al who had evidenced that neural stem cells survive
when grafted into newborn rat cochleae adopting
the morphologies and positions of hair cells and by
Rivolta et al who by murine embryonic cells had
generated inner ear progenitor cells subsequently
differentiated into hair cells(40,41).
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